As a result of the new non-decision by the Paff Committee on the renewal for the use of glyphosate, Agrofarma reiterates its appreciation for the European executive will to reach a decision supported by a qualified majority of Member States but It expresses its concern at the fact that this has not even materialized in front of the Commission's latest proposal ". So Agrofarma (the agrochemicals business national association that is part of Federchimica) intervenes in the debate around the glyphosate and stresses once again the absence of scientific evidence to justify the reduction of the period of authorization than standard 15 years. "The Association - says the statement released a few days ago - is aware that there are still serious concerns in a public opinion but believes that the evidence in support of the renewal is clear and irrefutable and supported by regulatory authorities around the world and not only European. "The association's hope is that they will continue efforts to reach a decision about the herbicide before the authorization expires."Glyphosate - explanatory Agrofarma - on the basis of the broad spectrum of studies currently available, including those on which it based the judgment of probable carcinogenicity of IARC, has been rated 'probably not carcinogenic' by EFSA, the only scientific body specifically appointed to this task by the European authorities and member states. Even FAO and WHO (including the IARC is part), after a meeting of 16 May of the Panel of Experts on Pesticide Residues in Food and the Environment, is They have jointly expressed for unlikely carcinogenicity of the substance ".What would happen if the authorization was not renewed? Agrofarma notes that in this way would be severely weakened "the architecture and the authority of the scientific system of authorization and control of all agricultural chemicals